Clinical Trial: LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas
Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Condition: Recurrent Glioblastoma
Study Type: Interventional
Official Title: Safety and Efficacy of LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas
Brief Summary:
This study aims to investigate the safety and efficacy of Laser Interstitial Thermal Therapy (LITT) combined with postoperative early use of temozolomide in treating recurrent glioblastomas.
Read more